文献速递胸部神经技术与安全CTMRPET

小细胞肺癌分期:传统分期检查、FDG PET/CT、全身MRI与配准FDG PET/MRI的前瞻性比较

Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI.
PubMed 文献 · AJR Am J Roentgenol · 2021-12-08

前瞻性纳入98例小细胞肺癌患者,于治疗前2周内完成传统分期检查、FDG PET/CT与全身MRI并生成配准FDG PET/MRI。全身MRI和FDG PET/MRI在T分期及TNM分期准确率上高于FDG PET/CT,三种先进方法在N、M及VALSG分期上均高于传统检查。

要点

  • 全身MRI和FDG PET/MRI的T分期准确率均为94.9%,高于FDG PET/CT的85.7%。
  • TNM分期准确率全身MRI 88.8%、FDG PET/MRI 86.7%,高于FDG PET/CT 77.6%和传统检查72.4%。
  • M分期准确率全身MRI、FDG PET/MRI和FDG PET/CT均为94.9%,高于传统检查的84.7%。

核心结论

  • FDG PET/CT、全身MRI和配准FDG PET/MRI在小细胞肺癌多个分期终点上优于传统检查;全身MRI和FDG PET/MRI在T分期及因此的TNM分期上优于FDG PET/CT,提示MRI有助于评估小细胞肺癌局部侵犯范围。

研究设计与样本

  • 前瞻性研究纳入98例小细胞肺癌患者(男64例、女34例,中位年龄74岁),治疗前2周内完成传统分期检查、FDG PET/CT和全身MRI并生成配准FDG PET/MRI;以肿瘤委员会临床确定的分期为参考标准。

诊断标准与关键数值

  • T分期准确率:全身MRI 94.9%、FDG PET/MRI 94.9% vs FDG PET/CT 85.7%(p<.05)。N分期准确率:全身MRI 84.7%、FDG PET/MRI 83.7%、FDG PET/CT 81.6% vs 传统检查75.5%(p<.05)。M分期准确率:全身MRI 94.9%、FDG PET/MRI 94.9%、FDG PET/CT 94.9% vs 传统检查84.7%(p<.05)。TNM分期准确率:全身MRI 88.8%、FDG PET/MRI 86.7% vs FDG PET/CT 77.6%、传统检查72.4%(p<.05)。VALSG分期准确率:全身MRI 95.9%、FDG PET/MRI 95.9%、FDG PET/CT 98.0% vs 传统检查82.7%(p<.05)。观察者间一致性kappa系数在各影像检查和分期终点为0.81至0.94。

临床应用与阅片要点

  • 作者指出,纳入全身MRI或配准FDG PET/MRI任一方法可能改善小细胞肺癌的初始分期评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Whole-body MRI and FDG PET/MRI have shown encouraging results for staging of thoracic malignancy but are poorly studied for staging of small cell lung cancer (SCLC). OBJECTIVE. The purpose of our study was to compare the performance of conventional staging tests, FDG PET/CT, whole-body MRI, and FDG PET/MRI for staging of SCLC. METHODS. This prospective study included 98 patients (64 men, 34 women; median age, 74 years) with SCLC who underwent conventional staging tests (brain MRI; neck, chest, and abdominopelvic CT; and bone scintigraphy), FDG PET/CT, and whole-body MRI within 2 weeks before treatment; coregistered FDG PET/MRI was generated. Two nuclear medicine physicians independently reviewed conventional tests and FDG PET/CT examinations in separate sessions, and two chest radiologists independently reviewed whole-body MRI and FDG PET/MRI examinations in separate sessions. Readers assessed T, N, and M categories; TNM stage; and Veterans Administration Lung Cancer Study Group (VALSG) stage. Reader pairs subsequently reached consensus. Stages determined clinically during tumor board sessions served as the reference standard. RESULTS. Accuracy for T category was higher (p < .05) for whole-body MRI (94.9%) and FDG PET/MRI (94.9%) than for FDG PET/CT (85.7%). Accuracy for N category was higher (p < .05) for whole-body MRI (84.7%), FDG PET/MRI (83.7%), and FDG PET/CT (81.6%) than for conventional staging tests (75.5%). Accuracy for M category was higher (p < .05) for whole-body MRI (94.9%), FDG PET/MRI (94.9%), and FDG PET/CT (94.9%) than for conventional staging tests (84.7%). Accuracy for TNM stage was higher (p < .05) for whole-body MRI (88.8%) and FDG PET/MRI (86.7%) than for FDG PET/CT (77.6%) and conventional staging tests (72.4%). Accuracy for VALSG stage was higher (p < .05) for whole-body MRI (95.9%), FDG PET/MRI (95.9%), and FDG PET/CT (98.0%) than for conventional staging tests (82.7%). Interobserver agreement, expressed as kappa coefficients, ranged from 0.81 to 0.94 across imaging tests and staging endpoints. CONCLUSION. FDG PET/CT, whole-body MRI, and coregistered FDG PET/MRI outperformed conventional tests for various staging endpoints in patients with SCLC. Whole-body MRI and FDG PET/MRI outperformed FDG PET/CT for T category and thus TNM stage, indicating the utility of MRI for assessing extent of local invasion in SCLC. CLINICAL IMPACT. Incorporation of either MRI approach may improve initial staging evaluation in SCLC.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Ohno, Yoshikawa, Takenaka, et al. Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI. AJR Am J Roentgenol. 2021. PMID: 34877872. doi:10.2214/AJR.21.26868

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。